{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":3,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":42,"n_cols":5,"rows_kept":42,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[9,2,9,3],[9,4,9,5],[10,2,10,3],[10,4,10,5],[11,2,11,3],[11,4,11,5],[12,2,12,3],[13,2,13,3],[14,2,14,3],[15,2,15,3],[16,2,16,3],[19,2,19,3],[20,2,20,3],[24,2,24,3],[29,2,29,3],[29,4,29,5],[30,2,30,3],[30,4,30,5],[31,2,31,3],[31,4,31,5],[32,2,32,3],[33,2,33,3],[34,2,34,3],[35,2,35,3],[36,2,36,3],[37,2,37,3],[38,2,38,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA990009866150403321"]
[null,null,"Titolo",null,"New reflections on Primo Levi [Risorsa elettronica] : before and after Auschwitz / edited by Risa Sodi and Millicent Marcus"]
[null,null,"Pubbl/distr/stampa",null,"New York : Palgrave Macmillan : Ebrary [distributor], 2011"]
[null,null,"ISBN",null,"9780230119673"]
[null,null,"Collana",null,"Italian and Italian American studies"]
[null,null,"Disciplina",null,"853.914"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Risorsa elettronica"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910464794103321"]
[null,null,"Autore",null,"Ontaneda D."]
[null,null,"Titolo",null,"Multiple sclerosis : a guide to pharmacologic treatment / / D. Ontaneda"]
[null,null,"Pubbl/distr/stampa",null,"Torino, Italy : , : SEEd, , 2013"]
[null,null,"ISBN",null,"88-97419-48-8"]
[null,null,"Edizione",null,"[First edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (150 p.)"]
[null,null,"Soggetti",null,"Multiple sclerosis - Treatment"]
[{"$nulls":4},"Pharmacology"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"\"\"Title Page\"\"; \"\"Colophon\"\"; \"\"Table of Contents\"\"; \"\"Section I. Introduction\"\"; \"\"Scope\"\"; \"\"New Therapies and Risks\"\"; \"\"Overview of Multiple Sclerosis\"\"; \"\"Basic pathogenesis\"\"; \"\"Disease forms\"\"; \"\"Approach to treatment\"\"; \"\"Goals of treatment\"\"; \"\"Challenges\"\"; \"\"References\"\"; \"\"Section II. Disease Modifying Agents for Multiple Sclerosis\"\"; \"\"Interferon for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of Action\"\"; \"\"Efficacy\"\"; \"\"Safety and Risks\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Glatiramer acetate for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of Action\"\"; \"\"Efficacy\"\"; \"\"Safety and Risks\"\""]
[{"$nulls":4},"\"\"Conclusions\"\"\"\"References\"\"; \"\"Mitoxantrone for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of action\"\"; \"\"Efficacy\"\"; \"\"Safety and risks\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Natalizumab for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of Action\"\"; \"\"Efficacy\"\"; \"\"Safety and Risks\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Fingolimod for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of action\"\"; \"\"Efficacy\"\"; \"\"Safety and risks\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Teriflunomide for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of action\"\"; \"\"Efficacy\"\"; \"\"Safety and risks\"\"; \"\"Conclusion\"\"; \"\"References\"\""]
[{"$nulls":4},"\"\"Dimethyl fumarate for MS\"\"\"\"Introduction\"\"; \"\"Mechanism of action\"\"; \"\"Efficacy\"\"; \"\"Safety and risks\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Section III. Treatment of relapses\"\"; \"\"Defining Relapses\"\"; \"\"Introduction\"\"; \"\"Relapse symptoms\"\"; \"\"MRI in MS Relapses\"\"; \"\"Natural History of MS Relapses\"\"; \"\"References\"\"; \"\"Treatment of MS relapses\"\"; \"\"Introduction\"\"; \"\"Corticosteroids (CS) and ACTH\"\"; \"\"Plasma exchange\"\"; \"\"IVIG\"\"; \"\"References\"\"; \"\"Section IV. Emerging therapies for "]
[{"$nulls":4},"multiple sclerosis\"\"; \"\"Laquinimod for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of action\"\"; \"\"Efficacy\"\""]
[{"$nulls":4},"\"\"Safety and risks\"\"\"\"Conclusions\"\"; \"\"References\"\"; \"\"Alemtuzumab for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of action\"\"; \"\"Efficacy\"\"; \"\"Safety and risks\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Daclizumab for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of action\"\"; \"\"Efficacy\"\"; \"\"Safety and risks\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Ocrelizumab and Rituximab for MS\"\"; \"\"Introduction\"\"; \"\"Mechanism of action\"\"; \"\"Efficacy\"\"; \"\"Safety and risks\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Author\"\""]
[null,"3.","Record Nr.",null,"UNISA996688082403316"]
[null,null,"Autore",null,"PERLINGIERI, Pietro"]
[null,null,"Titolo",null,"Sulla natura liberatoria del versamento della somma dovuta nelle mani dell'ufficiale giudiziario all'atto del pignoramento / Pietro Perlingieri"]
[null,null,"Pubbl/distr/stampa",null,"Napoli, : Jovene, [1961]"]
[null,null,"Descrizione fisica",null,"[383]- 390 p. ; 24 cm"]
[null,null,"Disciplina",null,"347.45077"]
[null,null,"Soggetti",null,"Pignoramento - Italia"]
[null,null,"Collocazione",null,"XVI.7.Misc. 485"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Titolo della copertina"]
[{"$nulls":4},"Estratto da: Rivista di giurisprudenza, vol. 76, n. 7-8 (1961)"]